Ergomed Consulting: Strategic Expertise to Accelerate your Drug Development and Global Market Entry

Trial complexity. Regulatory hurdles. Evolving safety expectations. Any one of these can slow your product timeline, threaten long-term success—or even derail global market entry. Count on Ergomed Consulting to help navigate the challenges. In markets around the world, Ergomed Consulting provides the strategic expertise you need to streamline drug development across all phases, ensuring regulatory success, market readiness, and long-term product viability.

We bring global perspective. Local insight. And an eye for driving towards the outcomes that define success.

Drawing on decades of experience at the forefront of drug development, our team includes former regulators, key opinion leaders, and industry experts. This diverse background equips us with comprehensive insight into every aspect of the drug development lifecycle. We bolster that knowledge through close work with Ergomed’s operations, strategic solutions, and patient-centricity teams to gain integrated perspectives on the latest therapeutic developments, global challenges, and fresh opportunities to help advance therapies to patients in need.

Ergomed Consulting Services Include:

  • From early strategic planning to indication prioritization and gap analysis, our experts can help propel early-stage success. Our deep insights into regulatory strategy and clinical development planning, combined with global expertise, streamline your pathway to clinical trials and ensure your clinical development program is robustly positioned for success.

Global Multidisciplinary Expertise Can Help Catalyze Success

Across every phase of the product lifecycle, Ergomed Consulting experts elevate your product viability–from shortened pathways to trial to regulatory agility and compliance, expedited global entry to sustained competitive edge. It’s what we do.

KOLs, Former Regulators, Expert Strategists
12+ Areas of Expertise Backed by Decades of Experience
Complex Diseases and Novel Therapies
End-to-End Drug Development Advisory
Flexible Model and Bespoke Service
Global Perspective Combined with Local Insight

Ergomed Consulting Solutions

Ergomed Consulting provides expert guidance across the entire drug development lifecycle. From discovery through to post-market management, we support biopharma innovators in overcoming regulatory complexity, de-risking development, and maximizing global market potential. Our tailored solutions are designed to address your most pressing challenges—helping you navigate each critical phase with confidence.

Discovery & Preclinical Phase

In the early stages of drug development, companies often face significant challenges such as funding gaps, complex regulatory landscapes, and translational hurdles that can delay progress.

Clinical Research (Phases I–III)

Clinical development is often complicated by complex protocols, regulatory barriers, and fragmented market access strategies.

Market Application & Regulatory Review

During the market application and regulatory review phase, companies must navigate a complex regulatory framework, minimize the risk of submission delays, as well as disparate review and approval process.

Post-Market Safety & Lifecycle Management

Following market approval, evolving safety expectations, increasing demands for evidence generation, and lifecycle competition present ongoing challenges.

Strategic Pre-IND Consulting for Gene Therapy in Rare Leukemia

Our latest case study showcases how Ergomed Consulting guided a biotech innovator through the complexities of early development for a gene therapy targeting a rare form of leukemia.

Early Stage Development in Rare Pediatric Oncology

Our latest case study highlights how Ergomed Consulting supported a biotech company developing a novel therapy for a rare pediatric cancer—navigating the complexities of early-phase clinical development in an ultra-orphan indication.

Market Approval for a Novel Non-Hodgkin Lymphoma (NHL) Therapy

Our latest case study reveals how Ergomed Consulting partnered with a pharmaceutical company to successfully navigate the final stretch of drug development—securing market approval for a novel treatment in a competitive Non-Hodgkin Lymphoma (NHL) landscape.

Post-Market Safety & Risk Management in Duchenne Muscular Dystrophy (DMD)

Our latest case study highlights how Ergomed Consulting supported a pharmaceutical company specializing in rare neurological diseases to manage long-term safety and sustain market performance for a therapy treating Duchenne Muscular Dystrophy (DMD).

Team Member Spotlight: 


Nan Shao, Executive Vice President of Ergomed Consulting

Our Executive Vice President of Ergomed Consulting, Nan Shao, brings over two decades of strategic and operational leadership in drug development. With a strong foundation as a trained statistician and extensive experience in both pharmaceutical and CRO settings, Nan has successfully led initiatives spanning the entire drug development lifecycle across diverse therapeutic areas.

Her expertise encompasses scientific rigor and operational excellence, empowering stakeholders through strategic use of data, optimized trial strategies, and patient-centric innovations. Nan is recognized for building collaborative, consultative partnerships that drive meaningful outcomes for clients and advance patient care.

In her role, Nan continues to shape the strategic direction of Ergomed Consulting by integrating data-driven insights, scientific innovation, and a steadfast commitment to improving healthcare outcomes.

Navigate the Complexities of the Entire Drug Development Path with Ergomed Consulting

Ergomed Consulting delivers unrivaled industry insights, sharing comprehensive expertise across disciplines to provide integrated medical, scientific, statistical, and regulatory guidance throughout your clinical development programs. Our end-to-end support from early planning to market approval empowers you to mitigate risks, maximize investment value, and ultimately deliver better outcomes for patients.

Unparalleled Expertise,
Ergo, Flawless Execution

Contact Us

Our Complementary Services

See how Ergomed can support your clinical trial.

More Ergomed Services

Find out how Ergomed supports your clinical trial objectives.